Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...
A new study suggests that the brain processes information with high efficiency by synchronizing the physical wiring of neural networks with the varying speeds of local brain activity. Published in ...
Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...
COYA 303 is an investigational proprietary combination of LD-IL-2 and GLP-1RA for subcutaneous administration, under development for the treatment of diseases, including Alzheimer's Disease, driven by ...
Research headed by teams at the University of Rochester Center for Translational Medicine and the University of Copenhagen describes for the first time how a spreading wave of disruption and the flow ...